Posts Tagged ‘CAP’

Community-Acquired Pneumonia in Adults

Posted by • April 3rd, 2015

Antimicrobial choices for community-acquired pneumonia in hospitalized patients who do not require ICU-level care continue to be debated. In a new trial, empirical beta-lactam–based therapy with or without a macrolide was compared with fluoroquinolones as initial treatment. The choice of empirical antibiotic treatment for patients with clinically suspected community-acquired pneumonia (CAP) who are admitted to non-intensive… Read More…

Initial Antibiotic Choice for Community Acquired Pneumonia

Posted by • April 2nd, 2015

The basic symptoms which occur in pneumonia … are as follows: acute fever, sticking pain in the side, short rapid breaths, serrated pulse and cough.   – Maimonides (1138–1204 AD) Antibiotic treatment of community-acquired pneumonia (CAP) is one of the most remarkable medical developments of the 20th century, yet the choice of initial antibiotics is not… Read More…

Community-Acquired Pneumonia

Posted by • October 24th, 2014

Community-acquired pneumonia is a commonly diagnosed illness in which no causative organism is identified in half the cases. Application of molecular diagnostic techniques has the potential to lead to more targeted therapy in the face of increasing antibiotic resistance. A new review article looks at this topic. Community-acquired pneumonia (CAP) is a syndrome in which acute… Read More…

Community-Acquired Pneumonia

Posted by • February 7th, 2014

Treatment of community-acquired pneumonia typically involves either a respiratory fluoroquinolone or a combination of cephalosporin and a macrolide. Initial broad-spectrum antibiotic therapy should be targeted to patients selected according to risk factors or existing disease. The latest review in our Clinical Practice series is on this topic. Pneumonia is sometimes referred to as the forgotten killer…. Read More…